Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals-Reference-Cited by-同舟云学术

Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals

Published:2022-05-31 Issue:9 Volume:6 Page:2496-2512
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Fukumoto Tsuyoshi¹^ORCID,Minami Tatsuya¹^ORCID,Moriyama Makoto¹,Yamada Tomoharu¹,Wake Taijiro¹,Kinoshita Mizuki Nishibatake¹,Fujiwara Naoto¹^ORCID,Nakagomi Ryo¹,Nakatsuka Takuma¹^ORCID,Sato Masaya¹,Enooku Kenichiro¹,Nakagawa Hayato¹,Fujishiro Mitsuhiro¹,Shiina Shuichiro²,Koike Kazuhiko¹,Tateishi Ryosuke¹^ORCID

Affiliation:

1. Department of Gastroenterology Graduate School of Medicine The University of Tokyo Tokyo Japan

2. Department of Gastroenterology Juntendo University Tokyo Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.2010

Reference26 articles.

1. Hepatocellular Carcinoma

2. A global view of hepatocellular carcinoma: trends, risk, prevention and management